Epigenetic changes and alternate promoter usage by human colon cancers for expressing DCLK1-isoforms: Clinical ImplicationsMalaney R. O’Connell, Pomila Singh|Scientific Reports|2015Cited by 73
A novel antibody against cancer stem cell biomarker, DCLK1-S, is potentially useful for assessing colon cancer risk after screening colonoscopyShubhashish Sarkar, Pomila Singh|Laboratory Investigation|2017Cited by 40